Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
23,425,328
-
Share change
-
+8,933,876
-
Total reported value
-
$388,553,133
-
Put/Call ratio
-
129%
-
Price per share
-
$16.59
-
Number of holders
-
93
-
Value change
-
+$148,855,829
-
Number of buys
-
76
-
Number of sells
-
19
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q2 2016
As of 30 Jun 2016,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,425,328 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS CAPITAL MANAGEMENT LLC, Partner Fund Management, L.P., SECTORAL ASSET MANAGEMENT INC, venBio Select Advisor LLC, and Foresite Capital Management III, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.